Zuo Jin Wan, a traditional chinese herbal formula, reverses P-gp-mediated MDR in vitro and in vivo

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Sui, Hua ^a   Liu, Xuan ^a   Jin, Bao Hui ^a   Pan, Shu Fang ^a   Zhou, Li Hong ^a   Yu, Nikitin Alexander ^b   Wu, Jie ^c   Cai, Jian Feng ^d   Fan, Zhong Ze ^a   Zhu, Hui Rong ^a   Li, Qi ^a  

^a SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Department of Obstetrics Gynecology   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BREAST CANCER RESISTANCE PROTEIN; CHINESE DRUG; GLYCOPROTEIN; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; OXALIPLATIN; UNCLASSIFIED DRUG; ZUO JIN WAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CELL STRAIN HCT116; CELL VIABILITY; CHINESE MEDICINE; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOSE RESPONSE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM TOLERATED DOSE; MOLECULAR MECHANICS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR VOLUME; TUMOR XENOGRAFT;

EID: 84875514017     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/957078     Document Type: Article

References (35)

1. Sui H., Zhou S., Wang Y., Liu X., Zhou L., Yin P., Fan Z., Li Q., COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer. Carcinogenesis 2011 32 5 667 675 2-s2.0-79955775908 10.1093/carcin/bgr016
2. Sui H., Fan Z. Z., Li Q., Signal transduction pathways and transcriptional mechanisms of ABCB1/Pgp-mediated multiple drug resistance in human cancer cells. Journal of International Medical Research 2012 40 2 426 435 2-s2.0-84860480401
3. Sui H., Zhou L., Yin P., Wang Y., Fan Z., Zhou S., Li Q., JNK signal transduction pathway regulates MDR1/ p-glycoprotein-mediated multi drug resistance in colon carcinoma cells. World Chinese Journal of Digestology 2011 19 9 892 898 2-s2.0-79957847245
4. An G., Wu F., Morris M. E., 5,7-Dimethoxyflavone and multiple flavonoids in combination alter the ABCG2-mediated tissue distribution of mitoxantrone in mice. Pharmaceutical Research 2011 28 5 1090 1099 2-s2.0-79955627074 10.1007/s11095-011-0368-y
5. Slot A. J., Molinski S. V., Cole S. P., Mammalian multidrug-resistance proteins (MRPs). Essays in Biochemistry 2011 50 1 179 207
6. He S. M., Li R., Kanwar J. R., Zhou S. F., Structural and functional properties of human multidrug resistance protein 1 (MRP1/ABCC1). Current Medicinal Chemistry 2011 18 3 439 481 2-s2.0-79251514280
7. Taniguchi K., Wada M., Kohno K., Nakamura T., Kawabe T., Kawakami M., Kagotani K., Okumura K., Akiyama S. I., Kuwano M., A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. Cancer Research 1996 56 18 4124 4129 2-s2.0-9544233652 (Pubitemid 26305002)
8. Cascorbi I., Haenisch S., Pharmacogenetics of ATP-binding cassette transporters and clinical implications. Methods in Molecular Biology 2010 596 95 121 2-s2.0-73949145223
9. Saglam A., Hayran M., Uner A. H., Immunohistochemical expression of multidrug resistance proteins in mature T/NK-cell lymphomas. APMIS 2008 116 9 791 800 2-s2.0-57349109252 10.1111/j.1600-0463.2008.00974.x
10. Hu W. Q., Peng C. W., Li Y., The expression and significance of P-glycoprotein, lung resistance protein and multidrug resistance-associated protein in gastric cancer. Journal of Experimental & Clinical Cancer Research 2009 28 144
11. Li W., Chan S., Guo D., Chung M., Leung T., Yu P. H., Water extract of Rheum officinale Baill. induces apoptosis in human lung adenocarcinoma A549 and human breast cancer MCF-7 cell lines. Journal of Ethnopharmacology 2009 124 2 251 256 2-s2.0-67449158739 10.1016/j.jep.2009.04.030
12. Rasul A., Yu B., Yang L., Ali M., Khan M., Ma T., Yang H., Induction of mitochondria-mediated apoptosis in human gastric adenocarcinoma SGC-7901 cells by kuraridin and nor-kurarinone isolated from sophora flavescens. Asian Pacific Journal of Cancer Prevention 2011 12 10 2499 2504 2-s2.0-84858239009
13. Li Q., Sui H., Liu X., Qin J. M., Yin P. H., Fan Z. Z., Reversal effect of Jianpi Jiedu Recioe on JNK/SAPK signal transduction pathway-mediated multidrug resistance in human colon carcinoma cells. CJTCMP 2012 27 3 731 735
14. Min Y. D., Yang M. C., Lee K. H., Kim K. R., Choi S. U., Lee K. R., Protoberberine alkaloids and their reversal activity of P-gp expressed multidrug resistance (MDR) from the rhizome of Coptis japonica Makino. Archives of Pharmacal Research 2006 29 9 757 761
15. He C., Rong R., Liu J., Wan J., Zhou K., Kang J. X., Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells. Chinese Medicine 2012 7 1, article 11 10.1186/1749-8546-7-11
16. Yang J., Wu L., Tashino S., Onodera S., Ikejima T., Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radical Research 2007 41 10 1099 1108 2-s2.0-34748824207 10.1080/10715760701499356 (Pubitemid 47470847)
17. Wang X. N., Han X., Xu L. N., Enhancement of apoptosis of human hepatocellular carcinoma SMMC-7721 cells through synergy of berberine and evodiamine. Phytomedicine 2008 15 12 1062 1068 2-s2.0-56349149424 10.1016/j.phymed.2008.05.002
18. Yang Z. G., Chen A. Q., Liu B., Antiproliferation and apoptosis induced by evodiamine in human colorectal carcinoma cells (COLO-205). Chemistry & Biodiversity 2009 6 6 924 933
19. Zhao F. R., Mao H. P., Zhang H., Antagonistic effects of two herbs in Zuojin Wan, a traditional Chinese medicine formula, on catecholamine secretion in bovine adrenal medullary cells. Phytomedicine 2010 17 8-9 659 668 2-s2.0-77952290891 10.1016/j.phymed.2009.10.010
20. Kolinsky K., Shen B., Zhang Y., Kohles J., Dugan U., Zioncheck T. F., Heimbrook D., Packman K., Higgins B., In vivo activity of novel capecitabine regimens alone and with bevacizumab and oxaliplatin in colorectal cancer xenograft models. Molecular Cancer Therapeutics 2009 8 1 75 82 2-s2.0-58149521889 10.1158/1535-7163.MCT-08-0596
21. Mi Y., Liang Y., Huang H., Zhao H., Wu C., Wang F., Tao L., Zhang C., Dai C., Tiwari A. K., Ma X., To K. K. W., Ambudkar S. V., Chen Z., Fu L., Apatinib (YN968D1) reverses multidrug resistance by inhibiting the efflux function of multiple ATP-binding cassette transporters. Cancer Research 2010 70 20 7981 7991 2-s2.0-78049281857 10.1158/0008-5472.CAN-10-0111
22. Tang Q. F., Liu X., Ge Y., Experimental study on inhibiting proliferation and inducing apoptosis of zuo jin wan alcohol extracts on human gastric cancer cells infected by Helicobacter pylori. Chongqing Medicine 2012 41 15 1462 1464
23. Sui H., Zhou L. H., Liu X., COX-2 regulate MDR1/P-glycoprotein-mediated multidrug resistance in colon carcinoma cells. China Oncology 2011 21 4 241 246
24. Yang H., Hua M., Liu H., Tsai R., Pang S., Hsu P., Tang H., Yen T., Chuang C., An epirubicin-conjugated nanocarrier with MRI function to overcome lethal multidrug-resistant bladder cancer. Biomaterials 2012 33 15 3919 3930 2-s2.0-84858278474 10.1016/j.biomaterials.2012.02.020
25. Wang F., Mi Y. J., G. Chen X., Axitinib targeted cancer stemlike cells to enhance efficacy of chemotherapeutic drugs via inhibiting the drug transport function of ABCG2. Molecular Medicine 2012 18 1 887 898
26. Liu K. J., He J. H., Su X. D., Saracatinib (AZD0530) is a potent modulator of ABCB1-mediated multidrug resistance in vitro and in vivo. Journal of Cancer 2013 132 1 224 235
27. Sui H., Jin B. H., Yin P. H., Fan Z. Z., Li Q., Reversal effect of Jianpi Jiedu Recioe on multidrug resistance in human colon carcinoma cells. Chinese Journal of Experimental Traditional Medical Formulae 2012 18 9 181 185
28. Wang X., Xu L., Peng J., Liu K., Zhang L., Zhang Y., In vivo inhibition of s180 tumors by the synergistic effect of the chinese medicinal herbs coptis chinensis and evodia rutaecarpa. Planta Medica 2009 75 11 1215 1220 2-s2.0-70350757629 10.1055/s-0029-1185538
29. Ostruszka L. J., Shewach D. S., The role of cell cycle progression in radiosensitization by 2′2′-difluoro-2′-deoxycytidine. Cancer Research 2000 60 21 6080 6088 2-s2.0-0034326813
30. Gao J., He T., Li Y., Wang Y., A traditional chinese medicine formulation consisting of Rhizoma corydalis and Rhizoma curcumae exerts synergistic anti-tumor activity. Oncology Reports 2009 22 5 1077 1083 2-s2.0-70449394399 10.3892/or-00000539
31. Wang Y., Yang Z., Zhao X., Honokiol induces paraptosis and apoptosis and exhibits schedule-dependent synergy in combination with imatinib in human leukemia cells. Toxicology Mechanisms and Methods 2010 20 5 234 241 2-s2.0-77952816915 10.3109/15376511003758831
32. Chen Z., Ingouff M., Sundaresan V., Berger F., Chromatin assembly factor 1 regulates the cell cycle but not cell fate during male gametogenesis in Arabidopsis thaliana. Development 2008 135 1 65 73 2-s2.0-38949197834 10.1242/dev.010108 (Pubitemid 351209287)
33. Romanov V. S., Abramova M. V., Svetlikova S. B., p21Waf1 is required for cellular senescence but not for cell cycle arrest induced by the HDAC inhibitor sodium butyrate. Cell Cycle 2010 9 19 3945 3955 2-s2.0-77958449473 10.4161/cc.9.19.13160
34. Mistry P., Stewart A. J., Dangerfield W., In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576. Cancer Research 2001 61 2 749 758 2-s2.0-0035863315 (Pubitemid 32128642)
35. Chao D., Lin L., Kao S., Huang H., Chang C., Liang J., Wu S., Hsiang C., Ho T., Inhibitory effects of Zuo-Jin-Wan and its alkaloidal ingredients on activator protein 1, nuclear factor- B, and cellular transformation in HepG2 cells. Fitoterapia 2011 82 4 749 758 2-s2.0-79955478204 10.1016/j.fitote.2011. 02.009